Physician profile
Cindy A Codispoti
NPI 1366414427
$2,561.02
in general payments reported to CMS, 2019-2025
23 companies · $662 in 2025
The $662 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $96.42 · 2021: $215 · 2022: $460 · 2023: $513 · 2024: $379 · 2025: $662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,554.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $432.53 | 2019-2025 | |
| Amgen INC. | $336.21 | 2019-2025 | Repatha, Repatha, Prolia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $302.03 | 2019-2025 | Lifevest |
| Abbott Laboratories | $232.04 | 2021-2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $231.70 | 2020-2025 | Jardiance |
| Pfizer INC. | $193.77 | 2019-2025 | |
| Edwards Lifesciences Corporation | $126.26 | 2025 | Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $103.07 | 2019-2023 | Xarelto |
| Irhythm Technologies, INC. | $85.77 | 2022-2024 | Zio Monitor, Zio Xt Patch |
| Boston Scientific Corporation | $84.20 | 2019-2025 | Watchman Flx, Watchman Access System |
| Regeneron Healthcare Solutions, INC. | $61.47 | 2019-2025 | Evkeeza |
| Cvrx, INC. | $56.25 | 2024 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $52.81 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $46.65 | 2019-2023 | Eliquis, Camzyos |
| Novo Nordisk INC | $31.51 | 2020-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $29.44 | 2020-2021 | |
| Baxter Healthcare | $29.14 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $27.39 | 2022 | |
| Impulse Dynamics (USA) INC. | $26.99 | 2023 | Optimizer |
| Heartflow, INC. | $21.50 | 2024 | |
| Kyowa Kirin, INC. | $18.36 | 2025 | |
| Ascendis Pharma Endocrinology INC | $17.71 | 2025 | Yorvipath |
| Lilly USA, LLC | $14.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Codispoti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.